Treating Inflammatory Bowel Disease During Pregnancy: Risks and Safety of Drug Therapy.
- Published in:
- Drug Safety, 1999, v. 21, n. 4, p. 311, doi. 10.2165/00002018-199921040-00006
- By:
- Publication type:
- Article
Works matching IS 01145916 AND DT 1999 AND VI 21 AND IP 4
Results: 8
1
2
Antioxidant Vitamin Supplements: Update of Their Potential Benefits and Possible Risks.
- Published in:
- Drug Safety, 1999, v. 21, n. 4, p. 253, doi. 10.2165/00002018-199921040-00002
- By:
- Publication type:
- Article
3
Zanamivir: A Review of Clinical Safety.
- Published in:
- Drug Safety, 1999, v. 21, n. 4, p. 267
- By:
- Publication type:
- Article
4
Risk-Benefit Assessment of Opioids in Chronic Noncancer Pain.
- Published in:
- Drug Safety, 1999, v. 21, n. 4, p. 283, doi. 10.2165/00002018-199921040-00004
- By:
- Publication type:
- Article
5
Risks and Benefits of Aromatase Inhibitors in Postmenopausal Breast Cancer.
- Published in:
- Drug Safety, 1999, v. 21, n. 4, p. 297, doi. 10.2165/00002018-199921040-00005
- By:
- Publication type:
- Article
6
Leukotriene Modifiers and Churg-Strauss Syndrome: Adverse Effect or Response to Corticosteroid Withdrawal?
- Published in:
- Drug Safety, 1999, v. 21, n. 4, p. 241, doi. 10.2165/00002018-199921040-00001
- By:
- Publication type:
- Article
7
Comparative Safety and Tolerability of Clopidogrel and Aspirin: Results from CAPRIE.
- Published in:
- Drug Safety, 1999, v. 21, n. 4, p. 325, doi. 10.2165/00002018-199921040-00007
- By:
- Publication type:
- Article
8
Postmarketing Studies: The Work of the Drug Safety Research Unit.
- Published in:
- Drug Safety, 1999, v. 21, n. 4, p. 337, doi. 10.2165/00002018-199921040-00008
- By:
- Publication type:
- Article